{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:28:54Z","timestamp":1761514134888,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.clbc.2023.05.018","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T05:30:09Z","timestamp":1685597409000},"page":"672-679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sentinel Node Biopsy in Patients With Breast Carcinoma Without Axillary Involvement at Diagnosis Receiving Primary Systemic Therapy"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9274-4677","authenticated-orcid":false,"given":"Laura","family":"Garc\u00eda-Calvo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Covadonga","family":"Mart\u00ed \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia Hern\u00e1ndez","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto Berj\u00f3n","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo Arnedo","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 I.","family":"S\u00e1nchez-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.clbc.2023.05.018_bib0001","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2023.05.018_bib0002","doi-asserted-by":"crossref","unstructured":"Veronesi U, Paganelli G, Galimberti V, et\u00a0al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet;349(9069):1864-7","DOI":"10.1016\/S0140-6736(97)01004-0"},{"issue":"6","key":"10.1016\/j.clbc.2023.05.018_bib0003","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00268-001-0011-x","article-title":"Sentinel node biopsy in breast cancer: ALMANAC trial","volume":"25","author":"Clarke","year":"2001","journal-title":"World J Surg"},{"issue":"10","key":"10.1016\/j.clbc.2023.05.018_bib0004","doi-asserted-by":"crossref","first-page":"9C","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.05.018_bib0005","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/tbj.12568","article-title":"Patterns of care in the administration of neo-adjuvant chemotherapy for breast cancer. a population-based study","volume":"22","author":"Vugts","year":"2016","journal-title":"Breast J"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.018_bib0006","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.patol.2013.11.001","article-title":"Consenso sobre la biopsia selectiva del ganglio centinela en el c\u00e1ncer de mama. Revisi\u00f3n 2013 de la Sociedad Espa\u00f1ola de Senolog\u00eda y Patolog\u00eda Mamaria","volume":"47","author":"Bernet","year":"2014","journal-title":"Revista Espanola de Patologia"},{"issue":"4","key":"10.1016\/j.clbc.2023.05.018_bib0007","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.senol.2022.07.002","article-title":"Consenso de la Sociedad Espa\u00f1ola de Senolog\u00eda y Patolog\u00eda Mamaria (SESPM) sobre la biopsia selectiva del ganglio centinela (BSGC) y el manejo axilar en el c\u00e1ncer de mama","volume":"35","author":"Bernet","year":"2022","journal-title":"Revista de Senolog\u00eda y Patolog\u00eda Mamaria"},{"issue":"8","key":"10.1016\/j.clbc.2023.05.018_bib0008","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/annonc\/mdx308","article-title":"De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017","volume":"28","author":"Curigliano","year":"2017","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.018_bib0009","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-017-4164-1","article-title":"Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer","volume":"163","author":"Zetterlund","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.clbc.2023.05.018_bib0010","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1245\/s10434-013-2992-8","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis","volume":"20","author":"Park","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.018_bib0011","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.clbc.2016.06.020","article-title":"Feasibility and prognostic effect of sentinel lymph node biopsy after neoadjuvant chemotherapy in cytology-proven, node-positive breast cancer","volume":"17","author":"Park","year":"2017","journal-title":"Clin Breast Cancer"},{"issue":"28","key":"10.1016\/j.clbc.2023.05.018_bib0012","doi-asserted-by":"crossref","first-page":"46557","DOI":"10.18632\/oncotarget.15101","article-title":"Axillary staging in breast cancer patients treated with neoadjuvant chemotherapy in two Dutch phase III studies","volume":"8","author":"Vriens","year":"2017","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.clbc.2023.05.018_bib0013","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.ejca.2013.06.012","article-title":"Doxorubicin\/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer","volume":"49","author":"Vriens","year":"2013","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.clbc.2023.05.018_bib0014","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/annonc\/mdu102","article-title":"Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II\/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)","volume":"25","author":"Charehbili","year":"2014","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2023.05.018_bib0015","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1186\/s13058-014-0427-5","article-title":"Biology of breast cancer in young women","volume":"16","author":"Azim","year":"2014","journal-title":"Breast Cancer Res"},{"issue":"11","key":"10.1016\/j.clbc.2023.05.018_bib0016","doi-asserted-by":"crossref","first-page":"e7695","DOI":"10.1371\/journal.pone.0007695","article-title":"Breast cancer in young women: poor survival despite intensive treatment","volume":"4","author":"Fredholm","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.clbc.2023.05.018_bib0017","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jamcollsurg.2008.12.001","article-title":"Elevated Breast Cancer Mortality in Young Women (<40 Years) Compared with Older Women Is Attributed to Poorer Survival in Early Stage Disease","volume":"208","author":"Gnerlich","year":"2009","journal-title":"J Am Coll Surg"},{"issue":"14","key":"10.1016\/j.clbc.2023.05.018_bib0018","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.clbc.2023.05.018_bib0019","doi-asserted-by":"crossref","first-page":"e016260","DOI":"10.1371\/journal.pone.0162605","article-title":"The feasibility and accuracy of sentinel lymph node biopsy in initially clinically node-negative breast cancer after neoadjuvant chemotherapy: A systematic review and meta-analysis","volume":"11","author":"Geng","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.clbc.2023.05.018_bib0020","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.05.018_bib0021","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.adro.2019.09.006","article-title":"Regional recurrence rates with or without complete axillary dissection for breast cancer patients with node-positive disease on sentinel lymph node biopsy after neoadjuvant chemotherapy","volume":"5","author":"Ling","year":"2019","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.018_bib0022","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1470-2045(21)00589-1","article-title":"Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients","volume":"23","author":"Yau","year":"2022","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.018_bib0023","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10549-019-05446-y","article-title":"Research-based PAM50 signature and long-term breast cancer survival","volume":"179","author":"Pu","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"9938","key":"10.1016\/j.clbc.2023.05.018_bib0024","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.clbc.2023.05.018_bib0025","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","article-title":"Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18","volume":"15","author":"Fisher","year":"1997","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2023.05.018_bib0026","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1245\/s10434-020-09480-9","article-title":"The landmark series: neoadjuvant chemotherapy for triple-negative and HER2-positive breast cancer","volume":"28","author":"Leon-Ferre","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.05.018_bib0027","doi-asserted-by":"crossref","first-page":"34","DOI":"10.21037\/cco-20-164","article-title":"Local management after neoadjuvant treatment for breast cancer","volume":"9","author":"Sakai","year":"2020","journal-title":"Chin Clin Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2023.05.018_bib0028","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ejso.2008.01.015","article-title":"Breast conserving surgery after neoadjuvant therapy for large primary breast cancer","volume":"34","author":"Tiezzi","year":"2008","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.05.018_bib0029","first-page":"105","article-title":"Pathological complete response patients after neoadjuvant chemotherapy in breast cancer","volume":"76","author":"Takaoka","year":"2022","journal-title":"Acta Med Okayama"},{"issue":"10","key":"10.1016\/j.clbc.2023.05.018_bib0030","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.clbc.2023.05.018_bib0031","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12282-018-00934-3","article-title":"Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla","volume":"26","author":"Bi","year":"2019","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.018_bib0032","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jso.26236","article-title":"Leveraging the increased rates of pathologic complete response after neoadjuvant treatment in breast cancer to de-escalate surgical treatments","volume":"123","author":"Esgueva","year":"2021","journal-title":"J Surg Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923001404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923001404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:26:05Z","timestamp":1761513965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820923001404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1526820923001404"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2023.05.018","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sentinel Node Biopsy in Patients With Breast Carcinoma Without Axillary Involvement at Diagnosis Receiving Primary Systemic Therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2023.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}